These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37610002)

  • 1. Advantages and disadvantages of connected insulin pens in diabetes management.
    Lingen K; Pikounis T; Bellini N; Isaacs D
    Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37610002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review.
    Cranston I; Jamdade V; Liao B; Newson RS
    Adv Ther; 2023 May; 40(5):2015-2037. PubMed ID: 36928495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Precision Insulin Management With Smart Insulin Pens: Opening Up the Digital Door to People on Insulin Injection Therapy.
    MacLeod J; Vigersky RA
    J Diabetes Sci Technol; 2023 Mar; 17(2):283-289. PubMed ID: 36326233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN).
    Tejera-Pérez C; Chico A; Azriel-Mira S; Lardiés-Sánchez B; Gomez-Peralta F;
    Diabetes Ther; 2023 Jul; 14(7):1077-1091. PubMed ID: 37188930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Smart Pens Help Improve Diabetes Management?
    Sy SL; Munshi MM; Toschi E
    J Diabetes Sci Technol; 2022 May; 16(3):628-634. PubMed ID: 33084417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes.
    Seo J; Heidenreich S; Aldalooj E; Poon JL; Spaepen E; Eby EL; Newson RS
    Patient; 2023 Mar; 16(2):127-138. PubMed ID: 36437389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience and evaluation of reusable insulin pen devices among patients with diabetes in emerging countries.
    Tschiedel B; Almeida O; Redfearn J; Flacke F
    Diabetes Ther; 2014 Dec; 5(2):545-55. PubMed ID: 25213801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem.
    Steenkamp D; Eby EL; Gulati N; Liao B
    J Diabetes Sci Technol; 2022 Jul; 16(4):995-1002. PubMed ID: 33666097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Bolus Calculators and Connected Insulin Pens: A Smart Combination for Multiple Daily Injection Insulin Therapy.
    Ahn DT
    J Diabetes Sci Technol; 2022 May; 16(3):605-609. PubMed ID: 34933594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring.
    Rodbard D; Garg SK
    Diabetes Technol Ther; 2021 Mar; 23(3):221-226. PubMed ID: 33480828
    [No Abstract]   [Full Text] [Related]  

  • 14. STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen.
    Naïditch N; Mauchant C; Benabbad I; Hehn C; Joubert M; Thébaut JF; Rosilio M
    Diabetes Ther; 2023 Feb; 14(2):303-318. PubMed ID: 36422803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of insulin delivery pen devices.
    Kroon L
    J Am Pharm Assoc (2003); 2009; 49(5):e118-31. PubMed ID: 19692314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States.
    Thurman JE
    Endocr Pract; 2007 Oct; 13(6):672-8. PubMed ID: 17954427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Insulin Pens: Advancing Digital Transformation and a Connected Diabetes Care Ecosystem.
    Kompala T; Neinstein AB
    J Diabetes Sci Technol; 2022 May; 16(3):596-604. PubMed ID: 33435704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical aspects of insulin pen devices.
    Pearson TL
    J Diabetes Sci Technol; 2010 May; 4(3):522-31. PubMed ID: 20513316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital Diabetes Management: A Literature Review of Smart Insulin Pens.
    Heinemann L; Schnell O; Gehr B; Schloot NC; Görgens SW; Görgen C
    J Diabetes Sci Technol; 2022 May; 16(3):587-595. PubMed ID: 33430644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.